Prof_IanD Profile Banner
Ian Davis (Bluesky @profiand) Profile
Ian Davis (Bluesky @profiand)

@Prof_IanD

Followers
3K
Following
16K
Media
1K
Statuses
11K

Professor of medicine | medical oncologist | Head @EHCSMonash | Chair, @ANZUPtrials | husband, father, grandfather, blessed | want to make a positive difference

Naarm, Wurundjeri land
Joined June 2016
Don't wanna be here? Send us removal request.
@Prof_IanD
Ian Davis (Bluesky @profiand)
8 years
Happiness is an empty beach, the wind in your ears, your best friend by your side, and 0/8 feet on the ground
4
5
65
@Bobby_Cat123
CHEETOdaCAT
1 day
@miles_commodore He definitely was! My favorite sketch! 😹 https://t.co/9InNUrTvJS
0
2
2
@Prof_IanD
Ian Davis (Bluesky @profiand)
8 days
There’s no such thing as nominative determ…
0
0
0
@DrCatharineY
Dr. Catharine Young
11 days
After YEARS of disinformation about the HPV vaccine, which can prevent cervical cancer, here are the facts: 285 studies 132 million people in real-world data 157,414 in randomized trials ~80% reduction in cervical cancer when given before age 16 No increase in serious adverse
346
867
2K
@NEJM
NEJM
10 days
Perspective essay by Biren B. Kamdar, MD, MHS: Pistachio Ice Cream https://t.co/C3O32sA3Iz #MedicalEthics #MedicalPractice
0
5
18
@Prof_IanD
Ian Davis (Bluesky @profiand)
11 days
To @BassCoast - I noticed a few pieces of asphalt between the potholes on Bass Hwy
0
0
1
@Prof_IanD
Ian Davis (Bluesky @profiand)
29 days
Just occurred to me, and maybe someone who knows could confirm: does the “enfor” in enfortumab refer to the antibody’s target (Nectin-4)?
0
0
0
@Prof_IanD
Ian Davis (Bluesky @profiand)
1 month
Congratulations @dan_lubman FAHMS!
@EHCSMonash
EHCS Monash
1 month
Congratulations to Professor Dan Lubman AM FAHMS, on his election as a Fellow of @AAHMS_health! @TurningPointAU @easternhealthau @Monash_FMNHS https://t.co/fHc9tdeDJY
0
0
2
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
"The Marching Morons" by CM Kornbluth. https://t.co/gYA1HglTWI
@YouAreLobbyLud
Dr David Berger BSc MBBS MRCP(UK) FRACGP-RG DTM+H
2 months
@PeterHotez I have come to understand these people's thinking when confronted by evidential refutation. They say to themselves: "Even if it isn't true, it may as well be true, so I don't care." Philosophically, they occupy a "Russell's teapot" position, in which each valid refutation is met
0
0
0
@PBlanchardMD
Pierre Blanchard, MD
2 months
🚨ENZARAD at #ESMO25 presented by @DrPaulNguyen No improvement in MFS or OS with the addition of enzalutamide to high dose radiotherapy + 2y ADT in high risk #prostatecancer Possible benefit in cN1 pts or pts treated with pelvic RT.
3
44
87
@neerajaiims
Neeraj Agarwal, MD, FASCO
2 months
Fantastic talk by @DrPaulNguyen #ESMO25 👉result of ph3 Enzarad trial👉Addition of ENZA to ADT + radiation did not improve MFS in all high risk localized, the primary endpoint. However, node+ on CT/MRI pts derived benefit, like Stampede trial @OncoAlert @urotoday @PCF_Science
4
52
96
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
@oncology_bg @oncodaily @TheLancetOncol @SamuelXStevens @lateuwen Trial design to get a dodgy drug registered: - no crossover - substandard control - no access to post study Rx - don’t look in mirror Want to improve OS, patient well-being, do the right thing? - allow crossover - best comparator - best post-study treatment - assess sequencing
0
1
4
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
@oncology_bg @oncodaily @TheLancetOncol @SamuelXStevens @lateuwen Thanks. So much good stuff in there but here is one of the most important: crossover. If crossover contaminates OS then it simply tells you there is no OS value in bringing the drug earlier or combining with earlier line treatment - you could and should just use it sequentially.
0
3
7
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
It's always a good idea to listen and reflect whenever @ian_tannock has something to say. https://t.co/WPp4DiHJnr
Tweet card summary image
ascopubs.org
1
2
15
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
New term heard today: "Diminishing Relevance Syndrome," where once-great people try to maintain their dominance by undermining and belittling the efforts of others. Far better to celebrate and support the people trying hard to follow in your steps: a rising tide floats all boats.
0
3
16
@ANZUPtrials
ANZUP
2 months
The program is shaping up fast! We’re building in plenty of space for audience participation, live Q&A and open discussion, so you’ll have the chance to share your views and connect directly with experts. Don’t just attend—be part of the conversation! https://t.co/QJBZS9d3tt
0
2
2
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
Undecided ducks.
2
0
3
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
0
0
1
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
Here’s a thought: which one would involve the least amount of air travel carbon dioxide generation for delegates?
Tweet card summary image
abc.net.au
Australia and TĂźrkiye are at loggerheads over who will host the massive international event, with insiders suggesting the countries could share the hosting rights.
0
0
0
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
@Apple Aaaaaand it’s stopped working again, all by itself. @Apple @AppleSupport @MazdaAus this is just not acceptable - these bugs should be fixed before you roll out a new iOS. I see CarPlay failures have been a topic of discussion for months among beta testers of #iOS26.
0
0
1
@Prof_IanD
Ian Davis (Bluesky @profiand)
2 months
@Apple One more thing: please learn from my own unexpected and unwanted experience and note that you should not look at the CarPlay hashtag. It also contains content of a different nature that at the very least is NSFW.
0
0
0